ADVFN Logo ADVFN

Hot Features

Registration Strip Icon for charts Inscrivez-vous pour des graphiques en temps réel, des outils d'analyse et des prix.
Femasys Inc

Femasys Inc (FEMY)

1,05
0,04
(3,96%)
Fermé 23 Novembre 10:00PM
1,05
0,00
(0,00%)
Après les heures de négociation: 11:00PM

Outils de qualité professionnelle, pour des investisseurs individuels.

Statistiques et détails clés

Dernier
1,05
Prix Achat
1,04
Prix Vente
1,07
Volume échangé
150 615
1,02 Fourchette du Jour 1,095
0,734 Plage de 52 semaines 2,40
Cap du marché
Clôture Veille
1,01
Ouverture
1,02
Dernière Transaction
10
@
1.06
Dernière heure de transaction
Volume financier
US$ 159 308
VWAP
1,0577
Volume moyen (3 m)
164 652
Actions en circulation
22 898 468
Rendement du Dividende
-
Ratio Cours sur Bénéfices
-1,69
Bénéfice par action (BPA)
-0,62
Chiffre d'affairess
1,07M
Bénéfice net
-14,25M

À propos de Femasys Inc

Femasys Inc is a biomedical company focused on transforming women's healthcare by developing solutions and advancements providing clinical impact to address severely underserved areas. The company's mission is to provide women with minimally invasive, non-surgical product technologies, accessible in... Femasys Inc is a biomedical company focused on transforming women's healthcare by developing solutions and advancements providing clinical impact to address severely underserved areas. The company's mission is to provide women with minimally invasive, non-surgical product technologies, accessible in the office, improving patient care and overall health economics. Show more

Secteur
Surgical,med Instr,apparatus
Industrie
Surgical,med Instr,apparatus
Site Web
Siège social
Dover, Delaware, USA
Fondé
-
Femasys Inc est coté dans le secteur Surgical,med Instr,apparatus de la NASDAQ avec le ticker FEMY. Le dernier cours de clôture d'Femasys était de US$1,01. Au cours de la dernière année, les actions de Femasys ont été négociées dans une fourchette de prix de US$ 0,734 à US$ 2,40.

Femasys compte actuellement 22 898 468 actions en circulation. La capitalisation boursière d'Femasys est de US$23,13 million. Femasys a un ratio cours/bénéfice (ratio PE) de -1.69.

FEMY Dernières nouvelles

Femasys Announces Financial Results for Quarter Ended September 30, 2024, and Provides Corporate Update

ATLANTA, Nov. 12, 2024 (GLOBE NEWSWIRE) -- Femasys Inc. (NASDAQ: FEMY), a leading biomedical company focused on addressing significant unmet needs of women worldwide with a broad portfolio of...

Femasys to Exhibit at the Annual AAGL 2024 Global Conference

ATLANTA, Nov. 07, 2024 (GLOBE NEWSWIRE) -- Femasys, Inc., (Nasdaq: FEMY), a leading biomedical company focused on addressing significant unmet needs of women worldwide with a broad portfolio of...

Femasys Announces Issued U.S. Patent Covering FemBloc® Device for Female Permanent Birth Control

ATLANTA, Nov. 01, 2024 (GLOBE NEWSWIRE) -- Femasys Inc. (NASDAQ: FEMY), a leading biomedical company focused on addressing significant unmet needs of women worldwide with a broad portfolio of...

Femasys Announces Partnership with Boston IVF, Prominent Network of Fertility Centers, to Offer FemaSeed

ATLANTA, Oct. 30, 2024 (GLOBE NEWSWIRE) -- Femasys, Inc., (Nasdaq: FEMY), a leading biomedical company focused on addressing significant unmet needs of women worldwide with a broad portfolio of...

Femasys to Exhibit at ASRM 2024 and Participate in the Congress’ KEEPR Education Program

ATLANTA, Oct. 10, 2024 (GLOBE NEWSWIRE) -- Femasys, Inc., (Nasdaq: FEMY), a leading biomedical company focused on addressing significant unmet needs of women worldwide with a broad portfolio of...

Femasys to Participate in a Fireside Chat at the 2024 Maxim Healthcare Virtual Summit

ATLANTA, Oct. 08, 2024 (GLOBE NEWSWIRE) -- Femasys, Inc., (Nasdaq: FEMY), a leading biomedical company focused on addressing significant unmet needs of women worldwide with a broad portfolio of...

Femasys Receives Second Order from Spain Partners After Successfully Completing Commercial FemaSeed® Infertility Treatments

ATLANTA, Oct. 02, 2024 (GLOBE NEWSWIRE) -- Femasys, Inc., (Nasdaq: FEMY), a leading biomedical company focused on addressing significant unmet needs of women worldwide with a broad portfolio of...

PériodeVariationVariation %Ouver.HautBasMoyenne Vol. Quot.VWAP
10.066.060606060610.991.050.861776630.93681742CS
4-0.15-12.51.21.40.862591541.16042076CS
12-0.1-8.695652173911.151.40.861646521.15460693CS
26-0.19-15.32258064521.241.40.861692011.13506402CS
520.126413.68557817240.92362.40.7343663831.32224033CS
156-4.07-79.49218755.125.940.247913509011.83511292CS
260-12.03-91.972477064213.0813.750.247911947041.90983577CS

Moteurs

Voir tout
  • Volume
  • % Gagnants
  • % Perdants
SymbolePrixVol.
PDYNPalladyne AI Corporation
US$ 4,59
(129,50%)
83,07M
QMCOQuantum Corporation
US$ 9,11
(126,62%)
39,48M
NANano Labs Ltd
US$ 8,26
(89,02%)
2,03M
XCURExicure Inc
US$ 18,60
(71,27%)
4,59M
SKKSKK Holdings Limited
US$ 1,75
(59,09%)
107,47M
AMIXAutonomix Medical Inc
US$ 6,21
(-54,07%)
897,51k
CETXCemtrex Inc
US$ 0,1146
(-41,74%)
22,89M
MSWMing Shing Group Holdings Ltd
 5,90
(-35,52%)
417,08k
RMSGReal Messenger Corporation
US$ 3,09
(-26,25%)
305,85k
ENSCEnsysce Biosciences Inc
US$ 0,4414
(-25,49%)
3,93M
ELABElevai Labs Inc
US$ 0,0201
(-0,50%)
425,38M
NVDANVIDIA Corporation
US$ 141,95
(-3,22%)
236,51M
SMCISuper Micro Computer Inc
US$ 33,15
(11,62%)
159,61M
VRPXVirpax Pharmaceuticals Inc
US$ 0,5501
(-6,72%)
159,39M
SOUNSoundHound AI Inc
US$ 8,24
(18,05%)
107,91M
Aucune Discussion Trouvée
Ajouter une Discussion

Dernières Valeurs Consultées

Delayed Upgrade Clock